Lecanemab treatment modulates brain volume and cerebrospinal fluid pathways in early Alzheimer's disease: Insights from longitudinal magnetic resonance imaging.

Alzheimers Dement (Amst) · 2026 · PMC13240209 · PMID 42255966

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

PVS volume exhibited a mild declining trend over time (−0.01 ± 0.03%, PFDR = 0.09), which did not reach statistical significance (Figure 2 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.